CME GROUP INC. (CME) Financials
Annual revenue, profitability and per-share results for CME GROUP INC., as reported in SEC filings.
Revenue • FY2025
$6.52B
▲ 6.4%YoY
Net income • FY2025
$4.07B
▲ 15.5%YoY
Diluted EPS • FY2025
$11.16
▲ 15.4%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $6.52B | $4.07B | — | $11.16 | $4.19B | 64.9% | +6.4% |
| FY2024 | $6.13B | $3.53B | — | $9.67 | $3.6B | 64.1% | +9.9% |
| FY2023 | $5.58B | $3.23B | — | $8.86 | $3.38B | 61.6% | +11.2% |
| FY2022 | $5.02B | $2.69B | — | $7.40 | $2.97B | 60.1% | +7.0% |
Figures as reported in CME GROUP INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to CME
Never miss a CME filing.
Get an email when CME files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.